GlassScriptPhysician profile
Suzanne G Pratt
NPI 1235557158
$713.94
in general payments reported to CMS, 2019-2025
10 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $184 · 2021: $207 · 2022: $55.29 · 2023: $39.29 · 2024: $86.13 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $125.00 | 2025 | Rexulti |
| Allergan, INC. | $124.79 | 2020 | |
| Abbvie INC. | $121.54 | 2021 | |
| Neos Therapeutics, LP | $99.72 | 2020-2024 | Adzenys Xr-Odt |
| Vanda Pharmaceuticals INC. | $87.85 | 2024-2025 | Fanapt |
| Idorsia Pharmaceuticals US INC | $51.12 | 2022-2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $47.10 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $26.15 | 2022 | |
| Merck Sharp & Dohme LLC | $17.31 | 2022 | |
| Adlon Therapeutics L.P. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.